Skye Bioscience Inc. (SKYE)
NASDAQ: SKYE
· Real-Time Price · USD
3.53
0.26 (7.95%)
At close: Aug 15, 2025, 3:59 PM
3.51
-0.57%
After-hours: Aug 15, 2025, 07:36 PM EDT
Skye Bioscience Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 11.07B | -11.1M | -9.75M | -3.9M | -7.9M | -5.02M | -4.42M | -24.95M | -3.11M | -5.17M | -9.89M | -3.13M | -3.42M | -3.04M | -2.51M | -1.82M | -2.02M | -2.16M |
Depreciation & Amortization | -177.01M | 177.38K | 175.29K | 66K | 29.79K | 27.56K | 28.37K | 28.79K | 33.92K | 33.17K | 31.53K | 28.8K | 27.68K | 26.98K | 24.72K | 7.46K | 1.01K | 938.00 |
Stock-Based Compensation | -2.2B | 2.2M | 2.09M | 1.92M | 1.83M | 2.48M | 592.85K | 160.21K | 102.87K | 131.58K | 203.19K | 144.12K | 144.36K | 137.36K | 121.95K | 488.97K | 111.7K | 146.58K |
Other Working Capital | 3.38M | -1.68M | -658.67K | 1.38M | -1.54M | -1.23M | 365.09K | -501.62K | 621.4K | -252.89K | -1.86M | 321.31K | 127.23K | -149.73K | -197.66K | -34.23K | 203.61K | 156.59K |
Other Non-Cash Items | -8.72B | -9.18B | 178.32K | -6.19M | 507.12K | -907.94K | 64.56K | 21.29M | 30.33K | 1.66M | 6.33M | 159.31K | 150.57K | 111.18K | 6.57K | 151.27K | 148.99K | 379.84K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -189.65K | n/a | n/a |
Change in Working Capital | 4.75M | -461.45K | -869.44K | 2.84M | -1.56M | -1.29M | -110.57K | -592.15K | 952.55K | -719.13K | -1.55M | 738.45K | 195.58K | -146.99K | 390.73K | -119.78K | 90.93K | 285.07K |
Operating Cash Flow | -10.75M | -9.19B | -8.17M | -5.26M | -7.09M | -4.71M | -3.84M | -4.05M | -1.99M | -4.06M | -4.87M | -2.06M | -2.9M | -2.91M | -1.97M | -1.49M | -1.67M | -1.35M |
Capital Expenditures | 6.31M | -6.31M | -50.02K | -1.52M | -32.46K | -3.18K | -7.02K | -3.67K | n/a | -1.86K | -12.5K | -10.34K | -3.21K | -2K | -54.04K | -26.66K | 526.00 | -10.7K |
Cash Acquisitions | 89.36K | n/a | -1.22M | 72.84K | n/a | 1.15M | n/a | 1.08M | n/a | n/a | 5.31M | -355.72K | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | 12.78B | -12.8B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | 1.36M | n/a | n/a | n/a | -5.53M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -12.8B | n/a | n/a | n/a | n/a | n/a | 5.53M | n/a | n/a | 5.53M | 370.1K | n/a | -80.83K | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -11.86M | -12.81B | 90.41K | -1.45M | -32.46K | 1.14M | -7.02K | 1.07M | n/a | 5.53M | 5.67M | -366.07K | -84.04K | -2K | -54.04K | -26.66K | 526.00 | -10.7K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | -22.65K | 4.9M | -123.41K | -45.31K | 34.16K | -91.85K | -91.85K | -61.23K | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 83.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.97K | n/a | 7.42M | 1.7M | 4.04M |
Financial Cash Flow | 18.16K | n/a | 5.62K | n/a | -2.1M | 85.65M | -22.65K | 16.63M | -123.41K | -45.31K | 34.16K | -91.85K | -91.85K | -59.26K | -83.72K | 7.42M | 1.7M | 4.04M |
Net Cash Flow | -22.58M | -21.99B | -8.08M | -6.71M | -9.22M | 82.09M | -3.87M | 13.65M | -2.12M | 1.42M | 829.14K | -2.51M | -3.08M | -2.98M | -2.11M | 5.9M | 33.91K | 2.68M |
Free Cash Flow | 9.17B | -9.19B | -8.22M | -6.78M | -7.13M | -4.71M | -3.85M | -4.06M | -1.99M | -4.06M | -4.88M | -2.07M | -2.9M | -2.92M | -2.02M | -1.51M | -1.67M | -1.36M |